Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-11

FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for Amiodarone hydrochloride (Slate Run Pharmaceuticals) as a generic antiarrhythmic agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMIODARONE HYDROCHLORIDE (Amiodarone hydrochloride)

Snippet

ORIG AP for AMIODARONE HYDROCHLORIDE (AMIODARONE HYDROCHLORIDE)